The New Look Of Euroscience: Mapping Output And Impact

U.K. produces more papers than any other European nation, but articles from Switzerland carry more clout For centuries, the nations of Europe have been competing fiercely with one another. They have fought long and bitter battles over mere slivers of land. They have clashed repeatedly in pursuit of new markets. Fortunately, outright warfare over land and markets is largely a thing of the past. But there is one realm in which the competition, although more civilized, is still hotly contested

Written byDavid Pendlebury
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

For centuries, the nations of Europe have been competing fiercely with one another. They have fought long and bitter battles over mere slivers of land. They have clashed repeatedly in pursuit of new markets. Fortunately, outright warfare over land and markets is largely a thing of the past. But there is one realm in which the competition, although more civilized, is still hotly contested - science.

So, who's winning? The Scientist decided to take a look.

When measured according to volume of published scholarly papers, the United Kingdom clearly dominates the European scene, as is revealed in the accompanying map of Euroscience, 1988. However, in impact of scientific papers, it's Switzerland that sets the pace.

In this depiction, each nation has been drawn to a scale proportionate to the number of articles its scientists published last year (as a percentage of all European articles, about 300,000) in journals indexed in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies